|

Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer

RECRUITINGSponsored by Sydney Children's Hospitals Network
Actively Recruiting
SponsorSydney Children's Hospitals Network
Started2021-03-08
Est. completion2023-03-08
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04903782

Summary

Assessment of the utility of family-based (trio) whole-genome sequencing for cancer predisposition testing in sequential newly diagnosed paediatric and adolescent cancer patients

Eligibility

Healthy volunteers accepted
* New diagnosis of malignancy
* Age ≤ 21 years
* Written informed consent

Psychosocial component:

* Participants (≥ 12 years)
* Parent/caregiver(s) of participants
* Healthcare professionals involved in the care of patients enrolled in the study

Conditions3

CancerGenetic Predisposition to DiseaseNeoplastic Syndromes, Hereditary

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.